Expression of Cholesterol Sulfotransferase (SULT2B1b) in Human Skin and Primary Cultures of Human Epidermal Keratinocytes  by Higashi, Yuko et al.
Expression of Cholesterol Sulfotransferase (SULT2B1b) in Human
Skin and Primary Cultures of Human Epidermal Keratinocytes
Yuko Higashi, Hirotoshi Fuda, Hidekatsu Yanai, Young Lee, Tomoko Fukushige,w Tamotsu Kanzakiw and
Charles A. Strott
Section on Steroid Regulation, Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes
of Health, Bethesda, Maryland, USA; wDepartment of Dermatology, Faculty of Medicine, Kagoshima University, Sakuragaoka, Kagoshima, Japan
Cholesterol sulfate is a highly amphipathic molecule that is present in a relatively high concentration in the
epidermis of human skin, particularly in the granular layer. The physiologic signiﬁcance of this ﬁnding, however, is
not well-understood. Therefore, we examined expression of the gene encoding for the enzyme that sulfonates
cholesterol (SULT2B1b). Of the three enzymes known to sulfonate steroids/sterols, only the SULT2B1b isozyme
was detected in cultures of normal human epidermal keratinocytes (NHEK) in response to Ca2þ -induced terminal
differentiation as well as by normal human epidermal tissue. Immunocytochemical analysis of normal skin as well
as speciﬁc skin disorders was carried out. In normal skin, the expression of SULT2B1b was localized to the
granular layer of the epidermis similar to that of ﬁlaggrin, an acknowledged late marker of differentiation and in
contrast to that of involucrin, an early marker of terminal differentiation, which was expressed throughout the
suprabasal region. The conﬁnement of SULT2B1b to the granular layer coincides with this being the area with the
highest cholesterol sulfate content suggesting that the physiologic action of cholesterol sulfate is likely carried out
in this region of the living epidermis. Additionally, 88% of cholesterol sulfate in NHEK was membrane-associated
further suggesting a cellular location for cholesterol sulfate action.
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Cholesterol sulfate is a ubiquitous sulfolipid that has
emerged as a multifaceted molecule with regulatory
capabilities; it circulates at a relatively high concentration
on the order of 150–300 mg per 100 mL (Strott and Higashi,
2003). Cholesterol sulfate is particularly prominent in the
epidermis where it has been demonstrated to accumulate in
the stratum granulosum (Lampe et al, 1983). Furthermore,
epidermal keratinocytes accumulate cholesterol sulfate in
culture during squamous differentiation (Jetten et al, 1989).
Although cholesterol sulfoconjugating activity has been
studied in human epidermal keratinocytes (Jetten et al,
1989), there are no reports on the expression of the genes
involved in steroid/sterol sulfoconjugation in human skin or
cultures of human epidermal cells.
The enzyme that produces cholesterol sulfate was
recently identified in our laboratory as a member of the
cytosolic sulfotransferase (SULT) superfamily (Javitt et al,
2001). The SULTsuperfamily is divided into five families, one
of which (SULT2) is primarily engaged in the sulfoconjuga-
tion of neutral steroids and sterols (Nagata and Yamazoe,
2000). The human SULT2 family is further divided into two
subfamilies, i.e., SULT2A1 and SULT2B1; furthermore, the
SULT2B1 subfamily consists of two isoforms designated
SULT2B1a and SULT2B1b (Her et al, 1998). The prototypical
steroid/sterol sulfotransferase, i.e., SULT2A1, commonly
referred to dehydroepiandrosterone sulfotransferase, is
capable of sulfonating a variety of steroids as well as bile
acids (Radominska et al, 1990; Falany et al, 1994; Falany,
1997); however, it is only weakly active against cholesterol
as a substrate (Fuda et al, 2002). Similarly, SULT2B1a,
which preferentially sulfonates pregnenolone only weakly
sulfonates cholesterol (Fuda et al, 2002). In contrast to
SULT2A1 and SULT2B1a, however, SULT2B1b avidly sulfo-
nates cholesterol and in this regard is more than an order of
magnitude more active than the other SULT2 isozymes
(Fuda et al, 2002).
Because of the importance of cholesterol sulfate in
keratinocyte differentiation as well as development and
maintenance of the epidermal barrier, we have examined the
expression of SULT2B1b mRNA and protein in human skin
as well as cultured human epidermal keratinocytes that had
been subjected to Ca2þ -induced terminal differentiation.
Additionally, cholesterol sulfotransferase activity and the
subcellular localization of cholesterol sulfate during Ca2þ -
induction of keratinocyte development were examined.
Results
Expression of SULT2 isozymes SULT2A1, SULT2B1a,
and SULT2B1b mRNA and protein expression were
Abbreviations: NHEK, normal human epidermal keratinocytes;
PAPS, 30-phosphoadenosine 50-phosphosulfate; PBS, phosphate-
buffered saline; SULT, cytosolic sulfotransferase
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determined in normal human skin and primary cultures of
NHEK. In both normal skin and NHEK, only SULT2B1b
mRNA was expressed (Fig 1A). This was also the case for
protein expression in the epidermis where only SULT2B1b
protein was detected by western analysis (Fig 1B).
Calcium induction of SULT2B1b The effect of three Ca2þ
concentrations, i.e., 0.05, 0.2, and 1.2 mM, on the
quantitative expression of NHEK SULT2B1b mRNA and
protein was examined. NHEK cells reached confluency in
4–5 d at 0.5 mM Ca2þ concentration and 7–9 d at either
0.2 mM or 1.2 mM Ca2þ concentration. At all three Ca2þ
concentrations, the expression of SULT2B1b mRNA began
to rise progressively in a concentration-dependent fashion
by day 5 during the 9-d incubation period (Fig 2). The
degree of enhancement was least at 0.05 mM Ca2þ ,
intermediate with 0.2 mM Ca2þ and maximal at 1.2 mM
Ca2þ . The concentration-dependent inductionofSULT2B1b
mRNA was mirrored by the concentration-dependent
increase in SULT2B1b protein (Fig 2 inset).
Immunocytochemistry Staining for SULT2B1b in normal
human skin was to all intents and purposes confined to the
outer reaches of the living epidermis, i.e., the granular layer
(Fig 3A). Faint staining noted in the dermis was indis-
tinguishable from the light staining seen with pre-immune
serum and is thus presumed to be non-specific (not shown).
Whereas intense staining for involucrin was found through-
out the suprabasal region (Fig 3C), filaggrin staining was
confined to the granular layer of the living epidermis (Fig
3B). The staining pattern for SULT2B1b, however, did differ
from filaggrin in that staining for the latter protein was also
present in the stratum corneum (Fig 3B) in contrast to
SULT2B1b, which appeared to be absent from the non-
viable region of the epidermis (Fig 3A).
Figure 1
Expression of SULT2B1b in normal human skin and epidermal
keratinocytes. (A) Reverse transcription-PCR analysis of SULT2A1
(lanes 1,5), SULT2B1a (lanes 2,6), SULT2B1b (lanes 3, 7) and b-actin
(lanes 4, 8) of human skin (lanes 1–4) and NHEK after incubation with
1.2 mM Ca2þ for 9 days (lanes 5–8). (B) SULT2A1 and SULT2B1
isoforms were analyzed by immunoblotting. Extracts (30 mg) of normal
human epidermis (lanes 2, 4) and NHEK that had been grown in 1.2 mM
Ca2þ for 9 d (lanes 3, 5) were gel loaded. Positive controls were 15 ng
of recombinant SULT2A1 (lane 1) and 70 ng each of SULT2B1a and
SULT2B1b (lane 6).
Figure2
Ca2þ -induction of SULT2B1b mRNA and protein expression in
cultured normal human epidermal keratinocytes. Cells were treated
with 0.05, 0.2, or 1.2 mM Ca2þ . At the indicated times, cell extracts and
total RNA were prepared and analyzed by immunoblotting and real-
time PCR. The inset shows expression of SULT2B1b protein after
loading of 30 mg of cell extract. Real-time PCR values represent the
mean  SEM, n¼ 6. po0.005 vs 0.05 mM Ca2þ -maintained cells
using Scheffe’s F test; y,time-dependent significance (Kruskal–Wallis
ANOVA, po0.001) and po0.005 versus cells at day 0 by Scheffe’s F test.
Figure 3
Immunohistochemical detection of
SULT2B1b and barrier proteins in nor-
mal human skin. Tissues were stained
with antibody to SULT2B1 (A), filaggrin (B)
or involucrin (C). Scale bar¼ 10 mm.
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Additionally, epidermal expression of SULT2B1b was
examined in three pathologic conditions. In recessive
X-linked ichthyosis, SULT 2B1b expression was confined
to the granular layer (Fig 4A) in a pattern that is similar to
normal skin (Fig 3A). In lichen planus, the staining pattern for
SULT2B1b was quite striking in that it revealed strong
expression throughout the epidermis with the exception of
the stratum corneum (Fig 4B). On the other hand, SULT
2B1b expression in a psoriatic plaque was essentially
undetectable and was clearly absent in nucleated corneo-
cytes (Fig 4C).
Cholesterol sulfotransferase activity Cholesterol sulfo-
transferase activity exhibited by cultured NHEK grown in
either 0.05 or 1.2 mM Ca2þ was first determined at day 3 of
incubation, and whereas the subsequent increase in activity
was modest for cells maintained in 0.05 mM Ca2þ , the
increase in activity was much greater for NHEK maintained
in 1.2 mM Ca2þ (Fig 5). It should be noted that there is no
0 d value for absolute comparison as the cell count is too
low to obtain enough protein for analysis. Nonetheless,
NHEK exposed to 1.2 mM Ca2þ exhibited a striking increase
in cholesterol sulfotransferase activity by day 9 as compared
to the activity demonstrated by cells maintained in medium
containing 0.05 mM Ca2þ (Fig 5). Importantly, these results
mirror the effect of the Ca2þ concentration on the levels of
SULT2B1b expression in cultured NHEK (Fig 2 inset).
Cellular localization of cholesterol sulfate Cultured
NHEK were examined at day 9 during incubation at both
low and high Ca2þ concentrations. In a preliminary
experiment, we determined by RT-PCR that NHEK express
the enzyme that produces 30-phosphoadenosine 50-phos-
phosulfate (PAPS) the universal sulfonate donor molecule
required for all sulfotransferase reactions (data not pre-
sented). Since PAPS is produced from inorganic sulfate and
ATP in a two-step process (Lyle et al, 1994), we incubated
cells with 35SO4 of known specific activity for incorporation
into 35S-labeled PAPS. The mass of cholesterol sulfate
was then determined from the incorporation of 35SO4 into
cholesterol sulfate. As expected, NHEK produced a
significantly greater amount of cholesterol sulfate when
maintained at the higher Ca2þ concentration (Fig 6).
Interestingly, at both low and high Ca2þ concentrations
 90% of the cholesterol sulfate was located in the
membrane fraction, whereas only about 10% was in the
soluble fraction (Fig 6).
Nota bene In arriving at an estimate for cholesterol sulfate
at least two considerations had to be taken into account.
First, since the culture medium contains a total of 3.653 mM
sulfur in the form of SO4 as noted previously, a correction
was made in the 35SO4 specific activity to reflect this
dilution factor. Second, the 35S-labeled PAPS produced
Figure 4
Immunohistochemical detection of
SULT2B1b in disorders of human skin.
Tissues were stained with antibody to
SULT2B1 in recessive X-linked ichthyo-
sis (A), lichen planus (B), and psoriasis
vulgaris (C). Scale bar¼40 mm.
Figure5
Cholesterol sulfotransferase activity in cultures of normal human
epidermal keratinocytes. Cells were treated with either 0.05 or
1.2 mM Ca2þ . At the designated times, cells were detached, cytosol
prepared and assayed for enzymatic activity. Control indicates activity
in the absence of cytosol protein. Column heights represent mean
values (n¼ 4); error bars are indicated. po0.05 vs 0.05 mM Ca2þ -
maintained cells using Scheffe’s F test. y,Time-dependent significance
(Kruskal–Wallis ANOVA, po0.005) and po0.005 versus cells at day 3 by
Scheffe’s F test.
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from 35SO4 will also be diluted by the amount of
endogenous unlabeled PAPS that is present; however,
since the quantity of the latter is unknown a correction in
the final specific activity in this case was not possible, and
as a result the cholesterol sulfate levels reported are most
likely an underestimation. Nevertheless, since the aim of
this experiment was not to establish absolute values for
cholesterol sulfate but rather to simply compare low and
high calcium effects on cholesterol sulfate levels as well as
the partitioning of cholesterol sulfate between membrane
and cytosolic fractions, the conclusions drawn are con-
sidered valid.
Discussion
The end product of epidermal keratinocyte differentiation is
development of an effective physical barrier of cornified
squamous cells, i.e., the stratum corneum (Fuchs, 1990).
The water impermeable barrier is composed of a layer of
flattened anucleated corneocytes mortared together by lipid
lamellae atop a layer of cross-linked cell envelope proteins
anchored to a keratin filament–matrix complex (Nemes and
Steinert, 1999). Structural defects in any of the components
of this covering may lead to clinically significant disease
resulting from impairment in barrier function (Roop, 1995).
Notably, cholesterol sulfate has been found to be a
significant component of stratum corneum lipids (Gray
and Yardley, 1975; Long et al, 1985; Downing et al, 1987;
Bouwstra et al, 2000), and evidence suggests that this
highly amphipathic molecule plays a role in keratinocyte
differentiation and development of the barrier (Strott and
Higashi, 2003).
Interest in cholesterol sulfate as an important epidermal
factor stems from the discovery of high levels of this
sulfolipid in the epidermis of patients afflicted with the
hyperkeratotic scaling disorder known as recessive X-linked
ichthyosis (Williams and Elias, 1981), an abnormality that is
the consequence of a steroid sulfatase deficiency (Ballabio
and Shapiro, 1995). Subsequently, literature expounding on
various aspects of the significance of cholesterol sulfate in
epidermal tissue appeared, and although a definitive
function(s) for cholesterol sulfate in skin is(are) not clearly
understood, several significant actions have been ascribed
to it. For instance, cholesterol sulfate activates multiple
protein kinase C isozymes (Denning et al, 1995), is a potent
inhibitor of cholesterol synthesis (Williams et al, 1985), is
able to induce transcription of the gene for transglutami-
nase I, an essential cross-linking enzyme involved in barrier
formation (Kawabe et al, 1998), and is capable of regulating
transcription of the gene for involucrin, a major cross-linked
protein constituent of the insoluble cornified cell envelope
(Hanley et al, 2001).
Consistent with the involvement of cholesterol sulfate in
keratinocyte development was the finding of a progressive
expression of SULT2B1b mRNA in primary cultures of
NHEK during Ca2þ -induction of terminal differentiation
along with a parallel increase in SULT2B1b protein and
cholesterol sulfotransferase activity. It was also found that
an increase in the level of involucrin mRNA followed a
similar time-course as SULT2B1b induction (data not
presented).
Of the three known steroid/sterol sulfotransferase iso-
zymes, only SULT2B1b was expressed in skin and NHEK.
This would be the expected result if the sole purpose of
SULT2 expression in skin is the production of cholesterol
sulfate since SULT2B1b, in contrast to the other twoSULT2
isozymes, functions as a selective cholesterol sulfotransfer-
ase (Fuda et al, 2002). It is of interest that the expression of
SULT2B1b in skin is localized to the granular layer of the
living epidermis similar to filaggrin, which is a late marker of
keratinocyte differentiation (Fuchs, 1990), suggesting that
SULT2B1b is also a late marker of differentiation. In
contrast, involucrin, which is an early marker of keratinocyte
differentiation (Fuchs, 1990), is strongly expressed in the
immediate suprabasal spinous layer of the epidermis. It is
noteworthy that the presence of SULT2B1b in the granular
layer is consistent with this layer containing the highest
concentration of epidermal cholesterol sulfate (Lampe et al,
1983; Elias et al, 1984).
Immunohistochemical analysis of SULT2B1b in disorders
involving the integument revealed striking differences in
staining patterns. For instance, in psoriasis vulgaris,
SULT2B1b expression was essentially undetectable. Pre-
vious investigations revealed that whereas involucrin is
expressed in the psoriatic epidermis, late differentiation
markers such as profilaggrin and loricrin are greatly
diminished or absent (Ishida-Yamamoto et al, 2000). The
hallmark of psoriasis vulgaris is the absence of a granular
layer and the presence of nucleated corneocytes. Cell
envelopes form prematurely and are persistently involucrin-
positive suggesting that psoriatic cell envelopes remain in
their premature stage without further maturation (Ishida-
Yamamoto et al, 2000). Thus, in psoriasis vulgaris, the
apparent lack of normal cellular progression with formation
of a granular layer would seem to explain the lack of
expression of late markers of differentiation such as
Figure 6
Subcellular localization of cholesterol sulfate in culture of normal
human epidermal keratinocytes. Cells were cultured for 9 d in
medium containing either 0.05 or 1.2 mM Ca2þ and 20 mCi per mL
Na2
35SO4. Membrane and cytosol fractions were prepared and assayed
for cholesterol sulfate. The results are representative of two indepen-
dent experiments.
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profilaggrin, loricrin, and SULT2B1b. In contrast to psor-
iasis, expression of SULT 2B1b in lichen planus is observed
throughout the epidermis with the exception of the stratum
corneum consistent with this disorder being characterized
as one with a thickened granular layer (Kanitakis et al,
1988).
An interesting finding was that almost 90% of the
cholesterol sulfate formed during Ca2-induction was found
in the cellular membrane fraction with only 10% being
present in the soluble cell fraction. Cholesterol sulfate
localization to NHEK cellular membranes is consistent with
a previous report noting that cholesterol sulfate was present
in stratum corneum membranes (Elias et al, 1984). This
finding along with previous reports of cholesterol sulfate
localization to membranes of erythrocytes (Bleau et al,
1972; Bleau et al, 1974; Bleau et al, 1975) and spermatozoa
(Langlais et al, 1981; Roberts, 1987) suggests that cellular
membrane localization of cholesterol sulfate might be a
general phenomenon and further suggests that this is an
important determinant of its physiologic effect.
The localization of cholesterol sulfotransferase to the
granular layer of the epidermis just beneath the stratum
corneum along with the knowledge that this region of the
epidermis contains the highest content of cholesterol
sulfate strongly suggests that the principal function of this
sulfolipid is carried out primarily in the region of the
granular-stratum corneum junction. The epidermis is a
perpetually renewing tissue whereby keratinocytes arise
from stem cells in the basal layer, move through a series of
cellular differentiation events until as dead squames they
are finally sloughed off from the outer stratum corneum
(Roop, 1995). It was previously suggested that cholesterol
sulfate might play a significant role in the proper functioning
of the stratum corneum and the normal sloughing of dead
cells in a process termed desquamation (Long et al, 1985). It
has been demonstrated that cholesterol sulfate is able to
retard desquamation by inhibiting serine proteases in the
stratum corneum that are responsible for the degradation of
cell adhesion structures known as desmosomes (Sato et al,
1998). Additionally, cholesterol sulfate can influence cell
cohesiveness by affecting the stability of corneocyte lipid
bilayers (Bouwstra et al, 1999; Bouwstra et al, 2000). The
inhibiting influence of cholesterol sulfate on normal desqua-
mation, which presumably occurs maximally in the lower
stratum corneum would subsequently be removed by the
presence of a cholesterol sulfate sulfohydrolase in the outer
stratum corneum thus allowing normal desquamation to
occur (Ballabio and Shapiro, 1995). This hypothesis is
supported by the finding of markedly elevated cholesterol
sulfate in the stratum corneum of patients with X-linked
recessive ichthyosis (Williams and Elias, 1981), a scaling
disorder which is a form of abnormal desquamation
resulting from a deficiency in stratum corneum steroid
sulfatase activity (Elias et al, 1984). This hypothesis is
further supported by the observation that increased thick-
ness and scaling of the stratum corneum can be induced by
the topical application of cholesterol sulfate, which is taken
up and retained by the stratum corneum (Elias et al, 1984;
Maloney et al, 1984). These interesting observations
notwithstanding, however, the precise role of cholesterol
sulfate in the epidermis remains to be firmly established.
Materials and Methods
Chemicals Cholesterol sulfate, adenosine 30-phosphate 50-
phosphosulfate (purity480% by HPLC), calf collagen III, and
2-hydroxypropyl-b-cyclodextrin were purchased from Sigma (St
Louis, Missouri). Organic solvents were purchased from Mallinck-
rodt Baker (Paris, Kentucky). Oligonucleotides were obtained from
Gene Probe Technologies (Gaithersburg, Maryland). 3H-Cholester-
ol (60 Ci per mmol) and Na2
35SO4 (1494 Ci per mmol) were
purchased from Perkin-Elmer Life Sciences (Boston, Massachu-
setts). Silica gel TLC plates were obtained from Analtech (Newark,
Massachusetts), and proteinase inhibitor cocktail Set V was
obtained from Calbiochem (San Diego, California).
Cell culture Normal human epidermal keratinocytes (lot no.
15073) (obtained under informed consent and in adherence with
the Helsinki principles) (NHEK) obtained from Cambrex (East
Rutherford, New Jersey) were seeded in dishes that had been
collagen-coated by incubation in a solution consisting of 0.1 mg
per mL calf collagen III and 0.1 M acetic acid for 2 h at room
temperature then washed with phosphate-buffered saline (PBS).
NHEK were maintained in KGM-2 medium (Cambrex) containing
0.05 mM calcium and supplements (bovine pituitary extract,
epidermal growth factor, insulin, hydrocortisone, transferrin, epi-
nephrine, gentamicin sulfate, and amphotericin-B). KGM-2 medium
contains a total of 3.653 mM sulfur (2.743 mM FeSO4, 0.0169 mM
CuSO4, 0.8916 mM ZnSO4 and 0.001124 mM MnSO4). NHEK on the
third passage were used for all experiments. Cells (2.5  105) were
seeded on 10 cm plates and after 24 h the cultures were fed fresh
medium containing varying concentrations of calcium.
RT-PCR Total RNA was extracted from keratinocytes using
Absolutely RNA RT-PCR Miniprep Kit according to the manufac-
turer’s instructions (Stratagene, La Jolla, California). The RNA
samples were treated with DNase supplied with the kit. Reverse
transcription was performed using ThermoScript RT-PCR system
according to the manufacture’s instructions (Invitrogen, Carlsbad,
California). Briefly, utilizing 1 mg of either human skin total RNA
(Stratagene, lot no.0120484) or NHEK as a template first strand
cDNAs were made using 25 pmol oligo(dT)20 and 25 ng of random
hexamer primers in a 20 mL reaction volume. Following heat
denature at 651C for 5 min, reverse transcription was carried out at
251C for 10 min and then 601C for 50 min. Two microliter aliquots of
cDNA were used as templates. Primers used were 50-C(nt295)
ACCTCCCCATCCAGTTATTCC(nt316)-3
0 (sense) and 50-G(nt581)TTCT
TCCTGTGTCCTGTTTCAGC(nt558)-3
0 (antisense) for SULT2A1, 50-
T(nt269)CACCACTTTACAGAAGAGGGACTG(nt293)-3
0 (sense) and 50-
G(nt567)ATCTCGATCATCCAGGTCGTG(nt546)-3
0 (antisense) for SULT
2B1a, 50-G(nt112)GCTTGTGGGACACCTATGAAG(nt133)-30 (sense)
and 50-A(nt317)TCTCGATCATCCAGGTCGTGC(nt296)-30 (antisense)
for SULT2B1b and 50-C(nt261)TGGCACCACACCTTCTACAATG(nt283)
-30 (sense) and 50-A(nt651)ATGTCACGCACGATTTCCCGC(nt630)-30
(antisense) for b-actin. Expected sizes of SULT2A1, SULT2B1a,
SULT2B1b, and b-actin are, respectively, 286, 299, 206, and 369
bp. PCR conditions were: denaturing at 951C for 5 min, followed by
35 cycles of denaturing at 941C for 15 s, annealing at 551C for 15 s,
and extension at 721C for 30 s.
Real-time PCR Quantification of SULT2B1b mRNA was per-
formed using a fluorescence temperature cycler (LightCycler,
Roche Molecular Biochemicals, Indianapolis, Indiana) and SYBR
Green I as a double-strand DNA-specific binding dye according to
the manufacture’s instructions. Real-time PCR was performed
according to a previously published procedure using the same
primers that were used for RT-PCR (Shimizu et al, 2003).
Preparation of recombinant proteins Recombinant SULT2
subtypes were prepared and purified using the glutathione
S-transferase gene fusion system (Amersham Biosciences, Piscat-
away, New Jersey) according to a previously reported procedure
(Fuda et al, 2002).
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Antibody preparation Purified recombinant SULT2A1 and
SULT2B1b were used for immunization (Covance, Denver, Penn-
sylvania). Antibodies to the SULT2 isozymes were produced in
New Zealand white rabbits by a modification of the multiple
intradermal protocol (Vaitukaitis, 1981), and immune sera were
validated by western blot analysis using recombinant proteins. It
should be noted that because of the high homology of the
SULT2B1 isoforms (95% identical) the antiserum to SULT2B1b
completely cross-reacts with SULT2B1a. Nonetheless, the two
SULT2B1 isoforms can easily be distinguished on the basis of size.
Western blotting Skin tissue (lot no. 0041651) obtained from the
National Resource Center (Philadelphia, Pennsylvania) was incu-
bated in PBS for 3 min at 501C and the epidermis separated from
the dermis by gentle dissection. The epidermis was immediately
homogenized in a solution consisting of 0.25 M sucrose, 0.05 M
Tris (pH 7.2), 0.001M EDTA, and proteinase inhibitor cocktail using
a polytron homogenizer. Homogenates were centrifuged at
1000  g for 10 min and the supernatants decanted for analysis.
Cultured NHEK were washed with ice-cold PBS, scraped into
PBS containing proteinase inhibitor cocktail and sonicated on ice
for 10 s 3  . Samples were electrophoresed on 10% Bis–Tris Gels
(Invitrogen) and transferred to polyvinylidene fluoride membranes
(Millipore, Bedford, Maryland). Membranes were soaked in a
solution of 5% dry milk (Bio-Rad, Hercules, California) in Tris-
buffered saline (TBS) containing 0.05% Tween 20 for 30 min with
gentle shaking, after which they were exposed to either SULT2B1
antibody (1:1000) or SULT2A1 antibody (1:32000) for 1 h.
Membranes were washed 3  with TBS containing 0.05% Tween
20 and incubated with goat anti-rabbit antibody (1:55,000, KPL,
Gaithersburg, Maryland) for 30 min. Finally, membranes were
washed 3  in TBS containing 0.05% Tween 20, and signals were
detected with LumiGLO (KPL) using the manufacturer’s protocol
prior to exposing the membranes to Scientific Imaging Film
(Kodak, Rochester, New York).
Cholesterol sulfate and cholesterol sulfotransferase activity In
experiments involving assays of either cholesterol sulfate or
cholesterol sulfotransferase activity, NHEK were incubated with
either 0.5 or 1.2 mM Ca2þ for up to 9 d. Additionally, in studies
involving the assay of cholesterol sulfate, cells were incubated with
20 mCi per ml Na2
35SO4. At the end of each experiment, cells were
washed 2  with PBS, detached by scraping and homogenized
with 10 strokes of a Dounce homogenizer (KONTES, Vineland, NJ).
Nuclei and unbroken cells were pelleted by centrifugation at
1000  g for 10 min and the decanted supernatants centrifuged at
100, 000  g for 1 h. High-speed pellets were washed 2  with
PBS and used as membrane fractions, whereas the high-speed
supernatants constituted cytosolic fractions.
Cholesterol sulfotransferase activity was determined using
3H-cholesterol according to a previously published method (Fuda
et al, 2002). Samples (50 mL) consisted of 25-mg cytosolic protein
in 0.1 mM Tris-HCl (pH 7.5) containing 5 mM MgCl2, 0.2 mM
2-hydroxypropyl-b-cyclodextrin and 4% ethanol (vol/vol). Reac-
tions were carried out at 371C for 1 h, stopped by precipitation with
1 mL of ethanol for 30 min on ice and centrifuged. Supernatants
were reduced by evaporation, 40 mL of cholesterol sulfate in
methanol (0.25 mg per mL) were added as a carrier and the
samples applied to TLC plates that were developed in chloroform/
methanol/acetone/acetic acid/water (44:10:20:6:5). Following
chromatography, TLC plates were dried and exposed to I2 vapor
to visualize the cholesterol sulfate spots, which were excised and
the radioactivity determined by liquid scintillation spectrometry.
In the assay of cholesterol sulfate, samples were also subjected
to ethanol precipitation and processed as above.
Immunocytochemistry Tissue samples used in these studies
were obtained under a protocol approved by the Kagoshima
University Faculty of Medicine Human Research Committee. Skin
biopsies were obtained from healthy volunteers, as well as patients
afflicted with psoriasis vulgaris, lichen planus, and recessive
X-linked ichthyosis. Histochemical analysis was carried out using
the avidin–biotin complex immunoperoxidase method. Samples
were fixed in paraformaldehyde and embedded in paraffin.
Sections were subjected to a pre-treatment step whereby they
were immersed in 0.1% trypsin for 30 min at 371C. Endogenous
peroxidase activity was impeded with 1.5% hydrogen peroxide in
methanol for 10 min at room temperature after which sections were
blocked with a PBS solution containing either 5% goat serum for
SULT2B1b or 5% horse serum (Vector Laboratories, Burlingame,
California) for involucrin and filaggrin for 20 min at room
temperature. Sections were incubated for 1 h with rabbit anti-
SULT2B1b (1:500), mouse monoclonal anti-human involucrin (1:1)
(YLEM, Rome, Italy), or mouse monoclonal anti-human filaggrin
(1:200) (Biomedical Technologies, Stoughton, Massachusetts) in
PBS followed by washing with PBS, incubation with either
biotinylated antirabbit IgG (SULT2B1) or antimouse IgG (involucrin
and filaggrin) for 20 min and stained using Vectastain ABC Kit
(Vector Laboratories) according to the manufacturer’s instructions.
Staining was developed with diaminobenzidine (Vector labora-
tories), and after washing, slides were incubated in Myer’s
Hematoxylin (Muto Pure Chemicals, Tokyo, Japan).
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